Table 1.
Viruses | Viral Cargo | Cellular Target | Exosome Biogenesis |
Exosomes Roles in the Pathogenesis | Medical Usefulness and Applications | References |
---|---|---|---|---|---|---|
Adenovirus | mRNA and miRNA | dendritic cells | Developing of early endosome | Attaching of cell surface receptors onto host cells | The host body of HIV-1 inspires to be clear of viral factors by releasing them into exosomes |
[15,77] |
HSV-1 | VP16, Heat shock proteins, HSV gB, ICP 127, miRNA | Epithelial cells | Trafficking proteins, DNA, RNA and lipids |
Delivering of suppressed membrane protein 1 (LMP1) to host cells |
Exosomes suppress or stimulate the immune response (immunomodulators) | [15,78,79,80,81,82,83] |
Ebola | DNA | macrophage, dendritic cells, | early endosome development | Cell surface receptors Attachment | Clearing the host bodies from virions | [84,85] |
EBV | RNA, miRNA, LMP1, 2A, gp350, EBERs |
Lymphocytes | budding of endosomal multivesicular bodies |
Proliferation, viral reactivation apoptosis, immune evasion | Intercellular communication between cells of the immune system | [86,87,88,89,90,91] |
HCV | miRNA, CD9, CD63, CD 81, HCV gRNA, RNA |
Hepatocytes | receptor-mediated endocytosis, and plasma membrane fusion | viral maturation and immune evasion | Neutralizing antibodies are resistant to HCV transmission by exosomes as a potential immune evasion mechanism. | [92,93,94] |
Dengue virus | Immunoregulator molecules (MHCI and MCII) |
Monocytes, macrophages | Recruit ESCRTs to the endosomal membrane | Assembly, transfer of viral RNAs, and suppression of immune activation. | Development of antiviral and vaccine candidate | [95] |
HPV | immunoregulator molecules, miRNA | Epithelial cells | ESCRTs are delivered to the site of budding | Apoptosis, viral proliferation, | Promoting anti-apoptotic potential. | [96] |
CMV | CMV gB | WBC, epithelial cells | Stimulating membrane budding |
Improved viral pathogenicity, infection of myeloid dendritic cells |
Inflammatory and regulatory markers | [97] |
polyomaviruses, (JCPyV and BKPyV) | Virion particles and miRNA | kidney, bone marrow, and central nervous system (CNS) | Virions packaged within EVs and associated to vesicles surface | play a key role in the dissemination and spread of polyomaviruses | Enhanced viral transmission and can be used as biomarker | [98,99,100,101] |
Coxsackievirus B1 | Replication competent genome within EV | Epithelial cells | Increased EV biogenesis | Increase viral spread | prolonged viral replication through micro RNA packaged in exosomes and can be used biomarker | [102] |
Chikungna virus | apoptotic bodies | Skeletal muscles, brain, and liver cells | hijacking apoptotic bodies | Infectious virions hijacking apoptotic bodies. Increased viral spread | Increased viral spread and can be used as biomarker | [103] |
ZIKV | Macrophage-derived exosomes | Brain, skin, placenta, retina, testis, and kidney cells | Infection significantly increases EV formation | Induction of placental proinflammatory cytokine production. | EVs derived from the semen of a ZIKV-infected patient inhibited ZIKV and delivering therapeutics across brain barriers |
|
ZIKV NS5-mediated activation of NLRP3 | Activation of host inflammatory response and macrophage recruitment promotes inflammation | [104,105] | ||||
EV-bound ZIKV-RNA and E-protein | Increased ZIKV transmission across neurons | [106] | ||||
HIV | Cytoskeletal proteins (Actin, Tubulin, Lamin, Myosin)miRTAR, miRNA, Nef |
Lymphocytes | ESCRT I and IIenhance membrane budding |
Induce proinflammatory cytokines, inhibition of apoptosis, increased susceptibility of naïve T cells, downregulation of CD4 and MHC I, Support viral reproduction and pathogenesis |
Analytical indicators in HIV-1, antiviral activity | [107,108,109,110,111] |
HBV | HBsAg, DNA, RNA | Hepatocytes | Multivesicular bodies fuse with the plasma membrane and secrete exosomes | Innate immunity evasion, transmission regulators | Drug delivery candidates for the targeted or systematic vehicle to particular organs or tissues | [14,112,113] |
HAV | HAV particles, enzymes, HAV gRNA, | Hepatocytes | Transport of ESCRT III, VPS4B, and ALIX. through endosomal-sorting complexes | Increasing viral infectivity, innate immunity evasion, intercellular communications | Drug delivery candidates for the targeted or systematic vehicle to particular organs or tissues | [114] |
Rift Valley fever virus | Viral proteins, miRNA, mRNA | WBC | ESCRTs enhance membrane budding |
Immune evasion, apoptosis, enhance viral infectivity | Analytic indicators | [115] |
human T-lymphotropic virus |
mRNA, miRNA, trans-activator protein | Lymphocytes | ESCRTs Stimulate membrane budding |
Activate cytokines, damage to neurons, increase viral replication | Contribute to the pathology of the viral infection | [116,117,118] |
HHV-8 | RNA, miRNA | endothelial cells, WBC |
budding of endosomal multivesicular bodies |
cell metabolism, immune modulation | Intercellular communication between cells of the immune system | [119,120] |